February, 2024
February 2024
M T W T F S S
 1234
567891011
12131415161718
19202122232425
26272829  
Karen Knudsen: It is with great joy that we welcome him as one of our newest American Cancer Society Board members
Jan 14, 2024, 18:13

Karen Knudsen: It is with great joy that we welcome him as one of our newest American Cancer Society Board members

Karen Knudsen, CEO of the American Cancer Society and American Cancer Society Cancer Action Network, shared American Cancer Society’s post on LinkedIn and added:

Sean is a game changer, who has been a steadfast champion in the fight against cancer. It is with great joy that we welcome him as one of our newest American Cancer Society Board members.

In addition to his role as an analyst for ESPN, Sean has been a longtime supporter of ACS and has helped grow our Coaches vs Cancer program significantly. I look forward to working with him to expand our impact in the sports world. Welcome, Sean!”

Quoting American Cancer Society’s post:

“We are thrilled to welcome Sean Farnham as a member of the 2024 Board of Directors! As an ESPN analyst, avid Coaches vs. Cancer supporter and founder of Hoops from Home charity, Sean brings a unique blend of passion and experience to the board. Welcome, Sean!”

Source: Karen Knudsen/LinkedIn and American Cancer Society/LinkedIn

Karen E. Knudsen is the CEO of the American Cancer Society (ACS) and its advocacy affiliate, the American Cancer Society Cancer Action Network (ACS CAN). Prior to joining ACS, Dr. Knudsen served as executive vice president of Oncology Services and enterprise director for Sidney Kimmel Cancer Center at Jefferson Health. She also served as president for the Association of American Cancer Institutes (AACI), representing the 102 leading cancer centers in North America, and on the board of directors of the American Association for Cancer Research (AACR).

Dr. Knudsen currently holds leadership roles with some of the most important cancer entities in the United States. She serves on the board of advisors for the National Cancer Institute and on 12 external advisory boards for NCI-designated cancer centers. She is an active member of several committees with the American Society for Clinical Oncology (ASCO), in addition to serving on other academic and for-profit advisory boards.